The global autotransfusion devices market size is poised to grow by USD 76.23 million during 2020-2024, registering a CAGR of close to 6% during the forecast period.
Read the 151-page research report with TOC on "Autotransfusion
Devices Market Analysis Report by product (systems and accessories), by geography
(North America, Europe, Asia, and ROW), and Segment Forecasts, 2020-2024".
The market is driven by the rising number of cardiac and orthopedic
surgeries. In addition, continuous technological advances are anticipated to
further boost the growth of the autotransfusion devices market.
Blood transfusion is one of the key procedures to be performed during
the intraoperative or postoperative procedures. Allogenic blood transfusion is
mainly performed during the procedures, which may lead to various bacterial and
viral infections. As a result, to avoid the risk of infection, autologous
transfusions are being performed during these surgical procedures. Thus, an
increase in various surgical procedures across the globe is expected to drive
the global autotransfusion devices market growth during the forecast period.
Buy 1 Technavio report and get the
second for 50% off. Buy 2 Technavio reports and get the third for FREE.
View market snapshot before
purchasing
Major Five Autotransfusion Devices Market Companies:
Haemonetics Corp.
Headquartered in the US, Haemonetics Corp. offers products through
segments, namely plasma, blood center, and hospital. The company offers Cell
Saver 5+, Cell Saver Elite+, and Cell Saver Elite as the key product offerings
for the autotransfusion devices market. In May 2019, the company received
clearance for the expanded use of TEG 6s Hemostasis Analyzer System in adult
trauma settings.
LivaNova Plc
LivaNova Plc operates its business under two segments such as
cardiovascular and neuromodulation. In July 2019, the company launched Bi-Flow,
an innovative arterial femoral cannula to prevent limb ischemia during cardiac
surgery. The company offers XTRA as its key offering which features innovative
technological characteristics to help clinicians perform autotransfusion
effectively.
Medtronic Plc
Medtronic Plc has business operations under various segments, which
include cardiac and vascular group, minimally invasive therapies group,
restorative therapies group, and diabetes group. The company offers the autoLog
autotransfusion system with an effective design to provide autologous blood
during surgical procedures. In October 2019, the company launched GI Genius
intelligent endoscopy module in Spain.
Getinge AB
Getinge AB operates through various business segments including acute
care therapies, surgical workflows, and lifesciences. The company offers 2450
self-filling autotransfusion blood bags and 2550 in-line autotransfusion blood
bags as its key offerings.
Teleflex Inc.
Teleflex Inc. offers products through various business segments
including surgical North America, vascular North America, interventional North
America, anesthesia North America, EMEA, Asia, OEM, and all others. The company
offers the Pleur-evac autotransfusion capability, an autotransfusion blood bag
used during chest drainage. In May 2018, the company launched TrapLine catheter
in Europe and showcased Arrow AC3 Optimus Intra-Aortic Balloon Pump (IABP).
No comments:
Post a Comment